2021 Speakers
Our 2022 event is in planning, more information will come soon!

John Arthur

Director, Medicines Manufacturing Innovation Centre, Quality and Biologics
John is the Director of the Medicines Manufacturing Innovation Centre, Glasgow, a collaboration between CPI, University of Strathclyde, UK Research & Industry, Scottish Enterprise and founding industry partners, AstraZeneca and GSK. The centre will ensure the UK is a technology and innovation leader in pharmaceutical manufacturing, thereby boosting the competitiveness of both sectors. The initial focus will be on technology translation for small molecule drug manufacture.
Prior to joining CPI in October 2019 John worked for GSK, joining the company in 1986 as a Process Chemist at the Worthing Site. During his time on Site he held roles covering all aspects of the manufacturing supply chain from large scale fermentation, fine chemicals (both chemical and enzymatic conversions), Chemical Development and Secondary Sterile Operations.

Adeel Aslam

Technical Director at Bouygues Energies & Services, Industry

Nathan Barnett

Project Coordinator - Advanced Therapies Skills & Training Network (ATSTN) at RoslinCT
Nathan joined RoslinCT in April 2021 as the project coordinator for the ATSTN. He is responsible for coordinating Scotland’s four training providers deliver a range of courses in advanced therapies.
Nathan has over 20 years lab experience working as a pharmacologist in pharma for Organon and MSD, for the CRO, Covance and in the NHS for the Blood Transfusion Service. In between those roles he also established and successfully ran his own environmental surveying business.

Miguel O. Bernabeu

Senior Lecturer, Usher Institute, University of Edinburgh
After completing a doctorate in Computational Biology at the University of Oxford, I joined the Centre for Mathematics and Physics in the Life Sciences and Experimental Biology (CoMPLEX) in 2011, UCL, where I worked on characterising the relationship between haemodynamics and vascular remodelling with a combination of computational and experimental methods. My work featured in the New Scientist magazine (#2906, Feb 2013) and has been published in journals and international conferences. In 2015, I joined the The University of Edinburgh with a prestigious Chancellor’s Fellowship where I established my first research group at the Centre for Medical Informatics, Usher Institute. In May 2021, I was appointed Deputy Director of The Bayes Centre, the Universityʼs innovation hub for Data Science and Artificial Intelligence, where I am also responsible for research strategy and delivery through my role of Director of Research. You can learn more about The Bayes Centre and the opportunities it provides on Education, Research, Entrepreneurship, and Industrial Partnerships here: https://www.ed.ac.uk/bayes

Jacqueline Barry

Chief Clinical Officer, Clinical Translation and Delivery
Jacqueline Barry is the Chief Clinical Officer, responsible for Clinical Translation and Delivery activities and an Executive Director of the Cell and Gene Therapy Catapult. She has extensive experience in the development of advanced therapy medicinal products and leads a multi-disciplinary team of Nonclinical, Regulatory, Clinical Operations and Programme Management specialists. She also leads the coordination of the UK Advanced Therapy Treatment Centre Network and is a Director of the Global Alliance for iPSC Therapies.
She feels passionately about making advanced therapies available for patients and works closely with the MHRA and the NHS on the development of the ecosystems to support the adoption of these therapies. Prior her time at Cell and Gene Therapy Catapult, Jacqueline worked at the Scottish National Blood Transfusion Service where amongst other activities she designed the regulatory strategy for the Cellular Therapies for the Blood Transfusion Service and acted as Qualified Person for their release. She has a PhD from the University of Aberdeen and did post-doctoral research in neurophysiology at the University of Edinburgh.

Steve Bates

CEO of the UK Bioindustry Association
Steve Bates has been the CEO of the UK Bioindustry Association since 2012. He currently chairs the International Council of Biotech Associations and has been a Board member of Europabio since 2015. Steve is the visible face of the vibrant UK life sciences industry to government and media. He sits on the UK’s Life Sciences Council and Life Sciences Industrial Strategy Implementation Board. Steve has championed with government effective industrial incentives like the Biomedical Cataylst which have crowded-in private sector investment into UK SMES. He has forged links for the sector across the USA, Europe and in China. In his time at the BIA Steve has developed new member groups focused on cell and gene therapy, genomics and engineered biology. A strong advocate of partnership working, Steve champions sector collaboration with research charities and academia. Proud to lead an organisation with a diverse Board with over 40% female representation, Steve is committed to next generation talent and developing the skills needed for the sector to flourish. Before the BIA, Steve worked for Genzyme and as an advisor to the UK Government of Tony Blair. He was made OBE for services to innovation in 2017.

Euan Cameron

CEO and Founder COHESION Medical
Euan Cameron is the CEO and Founder of COHESION Medical, a “small-but-smart” award-winning AI-driven Digital Health company based in Glasgow. Over the last 30 years, Euan has applied his background in Medical Manufacturing Systems, Bioengineering and Data Research to develop a range of innovative digital products for condition early detection and risk profiling across cancer, inflammatory diseases and brain health. As a strong advocate of whole systems thinking, Euan founded COHESION to build safer, smarter and more sustainable health systems that are centred on the citizen. COHESION works with the NHS, Community Health, Third Sector and with international research, technology and life sciences partners.

Andrew Davies

Digital Health Lead, ABHI
Andrew is responsible for working with partners to ensure that the UK maximises the opportunities for citizen health and economic wealth by appropriate investment in data driven healthcare.
A vital element of this is building on the unique opportunities delivered by the NHS to enable industry to access robust, well-curated data within a strong ethical framework. Coupled with close engagement with national bodies to evolve regulatory and reimbursement systems, the aim is to create a strong infrastructure and commercial environment that can support the development and widespread adoption of the best HealthTech solutions.
Andrew has over 25 years' experience in the medical technology sector having worked within MedTech divisions of household names such as Thorn EMI, Philips and Bristol-Myers Squibb. He has held roles covering UK and international marketing, market access and business development across both capital and consumable equipment. He has a degree in Applied Physics and a post graduate diploma in marketing.

Mark Fish

Managing Director at Accenture’s Scientific Informatics Services Business
Mark Fish is a Managing Director in Accenture’s Scientific Informatics Services Business. Mark has over 20 years of experience in various leadership roles delivering innovative solutions to the pharmaceutical sector and is passionate about drug discovery and development, translation research and precision medicine, digital transformation, agile software development and analytical quality control automation.

Neil Fullerton

 Project and Communications Lead    
Neil Fullerton is the Project & Communications Lead for Brain Health Scotland. Brain Health Scotland was established by Scottish Government, in partnership with Alzheimer Scotland, to deliver national public health programmes and individually tailored interventions, working with all ages across Scotland, to support those at higher risk to maintain brain health and reduce their risk of developing brain diseases that can lead to dementia

Jann gardner

Chief Executive, NHS Golden Jubilee
Profession Jann Gardner took up the post of Chief Executive, NHS Golden Jubilee on 21 January 2019. With more than 25 years of NHS and private healthcare management experience, Jann has held a number of senior leadership roles within clinical, operational, strategy and transformation with the common denominator of excellent patient care and experience as the critical objective.
Having started her career as a clinical pharmacist, she worked through progressively senior roles in her professional field and then within wider hospital healthcare management. With a commitment to continuous personal development she holds, in addition to her undergraduate pharmacy degree, postgraduate qualifications in Clinical Pharmacy, Health Economics, Programme Management and an Executive MBA. She has a keen interest in robotics, innovation and the harnessing of eHealth solutions to accelerate outcomes and resilience.

Claire Gillespie

Digital Technologies Sector Skills Manager, Skills Development Scotland
Claire has worked in the skills sector for almost 20 years and within digital technology skills since 2014 when Skills Development Scotland launched the first Skills Investment Plan for the tech sector. The overarching aim is to support employers to fill the 13,000 digital technology jobs in Scotland each year. To achieve this, Claire leads a small team who works with technology employers to influence digital skills education, and where appropriate to develop additional interventions in response to employer needs. The team works closely with Scottish Government and local authorities and is currently the delivery lead for Scottish Government's Digital Start Fund, their Digital Economy Units digital skills funding, and the Safer Communities Cyber Resilience Skills Action Plan. We also work with Glasgow City Council and support delivery of the skills actions in their Digital Glasgow Strategy.

Giles Hamilton

CEO, Operating Partner, ODx Innovations
Giles is driven by a desire to help improve standards of care in medicine, through useful medical device development and enabling teams & companies to achieve their potential.

Barry HEavey

Managing Director at Accenture’s Digital Manufacturing and Quality
Barry is a Managing Director based in Dublin, Ireland and leads Accenture’s Digital Manufacturing and Quality offering for life sciences in Europe. He has over 20 years of experience in the pharmaceutical industry and holds a PhD in Genetics from the University of Vienna.

Emily Jefferson

HIC Director, University of Dundee
Emily has a degree in Biochemistry, a PhD in Bioinformatics and was employed as a post-doctoral researcher in Bioinformatics following her PhD. She now works to combine an understanding of medical research and academia with industry standard IT project management and software development experience and apply these skills to the field of Health Informatics and Data Science.
As the academic lead and Director of the Health Informatics Centre (HIC) at the University of Dundee since 2012, Emily has lead a team of 60 people providing services to over 600 different research projects providing expertise in health informatics, data science, data management, governance, and machine learning. She is responsible for an ISO27001 certified infrastructure and a Scottish Government accredited Safe Haven. As a Professor of Health Data Science, Emily is involved with a range of projects in the fields of data science, clinical imaging, data linkage and machine learning.

Fiona Kellas

Partner, Maucher Jenkins
Fiona is a UK and European Patent Attorney and is a partner within the life sciences team of the IP firm Maucher Jenkins. Fiona’s background is in science and she was awarded a PhD degree in biochemistry from the University of Cambridge in 2003. Fiona has gained significant IP experience in the life sciences and medtech areas. Fiona enjoys working with and advising all sizes of companies, from start up companies and entrepreneurs to SMEs and larger multi national companies.

David J Lowe

Clinical Director Scottish Health Industry Partnership
Clinical Director Scottish Health Industry Partnership (Scot Gov). Established EmQuire research group focusing on data, device and decisions within Emergency Medicine. Innovation work focused on developing AI/ML by embedding a data driven approach combined with patient co-management into clinical care pathways. He leads on range of projects including trauma for the STN (thetraumaapp.com), Dynamic COPD (support.nhscopd.scot) and OPERA (early diagnostic heart failure utilising AI). As Clinical Director for SHIP and the WoS test bed lead creating the infrastructure and conditions to develop innovative devices, services and solutions with a range of industry and academic partners both UK and international with a focus on validation and deployment within the NHS enabling worldwide scale and adoption.

Alix Mackay

Chair
Specialising in Life Sciences and Biotechnology, Alix Mackay combines 14 years of commercial leadership experience in the biopharmaceutical industry with the latest best practice in online marketing to support life sciences SMEs and start-ups, She's worked with businesses, spin-outs, academic teams and innovation centres across the UK to help them increase their presence in the market and build their commercial capabilities. Based in Glasgow, Alix co-leads Life Sciences Scotland's Marketing and Communications, is a professional member of the Royal Society of Chemistry and a member of IBioIC.

Moira Mackenzie

Deputy Chief Executive/Director of Innovation at Scotland’s Innovation Centre for Digital Health and Care (DHI)
Moira Mackenzie is the Deputy Chief Executive/Director of Innovation at Scotland’s Innovation Centre for Digital Health and Care (DHI). DHI plays a pivotal role inspiring, enabling and combining world-leading industry and academic expertise with service, business and technical innovation to create person-centred digital health and care innovations which positively impact society. Moira is also a member of the Scottish Government’s Digital Citizen Delivery Board, NHS & Social Care Test Bed Governance Group, SHTG MedTech Forum, Digital Telecare & Digital Approaches for Care Homes national groups

Katie Murray

Technical Director at MMIC, CPI
Katie is a chemical engineer with over 25 years' experience in the pharmaceutical industry. She started her career in process development and scale-up roles with both Merck and Co. in the US and AstraZeneca in the UK, before moving to technical leadership roles in the deployment of technology into large capital projects, also at AstraZeneca. Her expertise covers both drug substance and drug product development and manufacture. A year ago Katie joined the Centre for Process Innovation’s Medicines Manufacturing Innovation Centre (MMIC). This is a cross industry-academia-UK government collaboration to drive the adoption of more efficient, cost-effective and environmentally friendly technology to increase patient access to medicines and reduce the manufacturing carbon footprint, through the execution of ambitious, transformational Grand Challenges. As the Technical Director for MMIC, she is responsible for leading the development and delivery of the technology strategy and has accountability for the Grand Challenge portfolio.

Kevin Pollock

Senior Outcomes Research Scientist, Bristol Myers Squibb
Dr Kevin Pollock has been a Senior Outcomes Research Scientist with Bristol Myers Squibb for over 2 years. Working across the Innovative Medicines team, he provides Real World Evidence leadership to a number of teams in executing studies that assess population-based interventions. He worked within NHS Scotland for 16 years as an infectious disease epidemiologist in health protection, and has published in Lancet and BMJ using RWE from Scotland’s eDRIS database. He is currently collaborating on 2 RWE studies with Professor Nick Mills and Dr Ken Lee at NHS Lothian using DataLoch. He has been a Board Trustee with Jo’s Cervical Cancer Trust Since 2018.

Bjoern Schelter

PTauRx Data Analytics and Biostatistics Lead, and CEO GT Diagnostics
 Professor Schelter is Chair Professor in Applied Mathematics at the University of Aberdeen, Scotland. For more than 20 years, he has specialised in data-based modelling, model-based data analysis, and statistics with applications mainly in the Neurosciences. His scientific contributions split equally into developing novel statistical analysis tools and approaches and the application thereof. Since 2012 a particular focus area of his research and work is dementia. He contributes to the development of novel therapies through his role as Data Analytics and Biostatistics Lead at TauRx. It is the vision of GT Diagnostics of which he is CEO to develop novel diagnostic tools for dementia.

Dave Tudor

Managing Director, Medicines Manufacturing Innovation Centre, Quality and Biologics
Dave is the Managing Director of the Medicines Manufacturing Innovation Centre, Quality and Biologics. The centre will ensure the UK is a technology and innovation leader in pharmaceutical manufacturing, thereby boosting the competitiveness of both sectors. The initial focus will be on technology translation for small molecule drug manufacture.
Dave also leads the Biologics business unit, CPI’s Quality function, which includes GMP obligations, and CPIs PMO function. He plays an active role with a number of Governments and is currently co-chair of the Life Sciences Scotland Industry Leadership Group.

Obinna Ubah

Principal scientist at Elasmogen Ltd
Obinna is a principal scientist at Elasmogen Ltd. He is also a UKRI Future Leaders Fellow (cohort 5). Obinna holds a BPharm. degree from Nigeria, an MSc in Clinical Pharmacology (with distinction), PhD in Biomedical Sciences (SULSA/MSD Scholar) from the Univ. of Aberdeen, UK, and a PGCert in IP Law (2018, UNISA, South Africa). Obinna leads Elasmogen’s inflammation and autoimmune drug discovery research, utilising protein engineering techniques and the robustness of proprietary soloMER™ technology to develop novel, next-generation, super-potent drug modalities for the treatment of chronic diseases. His aspiration to become a KOL in the field of autoimmune disease was one of the most influential drivers behind the development of key pipeline assets at Elasmogen Ltd. The success of this research has also been accelerated through Obinna’s fostering of multiple regional and international collaborations and partnerships. Obinna retains a keen interest in higher education teaching and the commercialisation of research and holds an honorary lectureship position at the Univ. of Aberdeen. He is also president of a Scottish registered foundation (FISEA) focused on knowledge transfer in developing countries.

Harper VanSteenhouse

President and Co-Founder, BioClavis
Harper VanSteenhouse, PhD, is President and Co-Founder of Precision Diagnostics company—BioClavis Ltd. In addition, Harper (and BioClavis) have been assisting the NHS Test and Trace program as Site Director of the Lighthouse Laboratory in Glasgow, a large 95K sample/day coronavirus testing lab. Harper has extensive experience in both product commercialization and development/management, with a focus on strategic, financial, marketing and operations leadership. He is formally trained in cell and molecular developmental biology with a PhD in Neuroscience from University of California, San Diego. As VP of Technical Integration at BioSpyder, Harper joined the growing company to lead commercialization (sales, marketing, and business development) and ultimately the initiative to spin out BioClavis as a diagnostics company. 

John Waller

Chief Operating Officer, OracleBio
With 25 years of experience in the pharmaceutical industry, including roles at AstraZeneca, Schering-Plough and Merck & Co., John co-founded Quantitative Image Analysis CRO, OracleBio. As Chief Operating Officer, he has established the company as a market leader within its field, supporting the digital pathology programmes of major Pharma and Biotech companies around the globe. John oversees the development of agile and scalable IT capabilities to keep pace with advances in digital pathology, such as the adoption of Artificial Intelligence techniques and the increased use of complex multiplex images. This has allowed the company to not only be the go-to for complex image analysis, but also enabled them to build cutting-edge IT solutions specifically designed to optimise image storage, handling, and batch processing during quantitative image analysis.

Steph Wright

Director of Healthcare & Wellbeing Engagement/Head of Scottish AI Alliance Support Circle, The Data Lab
Steph is a data science enthusiast with specific experience of the healthcare domain. In addition to her role as Director of Healthcare & Wellbeing Engagement, she also heads up the Scottish AI Alliance team in its efforts to deliver Scotland’s AI Strategy. She has a diverse background ranging from astrophysics to genomics in academia and film & TV to dance in the arts and the third sector. A project and programme management professional, she loves to develop and build collaborations across organisations to help people with their data/AI journey!
#ScotLifeSci22
Copyright ©2022 National World Publishing Ltd
twitter
Facebook Twitter Google+ LinkedIn